Assessment of somatostatin receptor expression in predicting results of PRRT (peptide receptor radionuclide therapy) in disseminated neuroendocrine tumours (NET)

被引：0
|
作者：
Hubalewska-Dydejayk, Alicja B. [1 ]
Sowa-Staszczak, Anna [1 ]
Trofimiuk, Malgorzata [1 ]
Stefanska, Agnieszka [1 ]
Wierzchowski, Wojciech [2 ]
Kunikowska, Jolanta [3 ]
Pach, Dorota [1 ]
Tomaszewska, Romana [2 ]
机构：
[1] Jagiellonian Univ, Coll Med, Nucl Med Unit, Dept Endocrinol, Krakow, Poland
[2] Jagiellonian Univ, Coll Med, Dept Pathol, Krakow, Poland
[3] Med Univ, Dept Nucl Med, Warsaw, Poland
来源：
ENDOCRINE JOURNAL | 2010年 / 57卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S443 / S443
页数：1
相关论文
共 50 条
  • [21] Peptide receptor radionuclide therapy (PRRT) using somatostatin analogs.
    Capello, A
    Krenning, EP
    Bernard, HF
    Breeman, WA
    Van Den Aardweg, G
    De Jong, M
    JOURNAL OF NUCLEAR MEDICINE, 2001, 42 (05) : 125P - 125P
  • [22] Peptide receptor radionuclide therapy (PRRT) for progressive, somatostatin receptor positive pheochromocytoma/paraganglioma
    Prasad, V.
    Zachert, C.
    Schuchardt, C.
    Wortmann, R.
    Baum, R. P.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2008, 35 : S351 - S351
  • [23] Quality of life assessment following peptide receptor radionuclide therapy (PRRT) of pancreatic neuroendocrine tumor (P-NET)
    Marinova, Milka
    Muecke, Martin
    Mahlberg, Lukas
    Essler, Markus
    Cuhls, Henning
    Radbruch, Lukas
    Ahmadzadehfar, Hojjat
    JOURNAL OF NUCLEAR MEDICINE, 2016, 57
  • [24] Efficacy and tolerability of peptide receptor radionuclide therapy (PRRT) in advanced metastatic bronchial neuroendocrine tumours (NETs)
    Mirvis, Eitan
    Toumpanakis, Christos
    Mandair, Dalvinder
    Gnanasegaran, Gopinath
    Caplin, Martyn
    Navalkissoor, Shaunak
    LUNG CANCER, 2020, 150 : 70 - 75
  • [25] Peptide Receptor Radionuclide Therapy with radiolabelled somatostatin analogues in patients with somatostatin receptor positive tumours
    Van Essen, Martijn
    Krenning, Eric P.
    De Jong, Marion
    Valkema, Roelf
    Kwekkeboom, Dik J.
    ACTA ONCOLOGICA, 2007, 46 (06) : 723 - 734
  • [26] Importance of peptide receptor radionuclide therapy for the management of neuroendocrine tumours
    Ciuciulkaite, I.
    Herrmann, K.
    Lahner, H.
    ONKOLOGIE, 2024, 30 (11): : 1065 - 1074
  • [27] Management of neuroendocrine tumours of the rectum (rNET) with Ga-68 somatostatin receptor PET/CT (SR-PET/CT) and Peptide Receptor Radionuclide Therapy (PRRT)
    Prasad, V.
    Kaemmerer, D.
    Hommann, M.
    Hoersch, D.
    Zachert, C.
    Baum, R. P.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 : S201 - S201
  • [28] Neoadjuvant therapy with peptide receptor radionuclide therapy for pancreatic neuroendocrine tumours
    Hallet, Julie
    Soreide, Kjetil
    BRITISH JOURNAL OF SURGERY, 2024, 111 (09)
  • [29] Peptide Receptor Radionuclide Therapy In Broncopulmonary Neuroendocrine Tumours - Results Of A Single Centre Experience
    Ferreira, G.
    Castro, S.
    Costa, C.
    Violante, L.
    Teixeira, J.
    Duarte, H.
    Sampaio, I. L.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (SUPPL 1) : S89 - S89
  • [30] Peptide receptor radionuclide therapy (PRRT) for neuroendocrine tumors (NET): A two-year single institution experience
    Duan, Heying
    Ninatti, Gaia
    Girod, Bradley
    Ferri, Valentina
    Guja, Kip
    Song, Hong
    Kunz, Pamela
    Fisher, George
    Iagaru, Andrei
    Aparici, Carina Mari
    JOURNAL OF NUCLEAR MEDICINE, 2020, 61
12345